Suppr超能文献

阿维A在人体内的顺反异构化

Cis-trans interconversion of acitretin in man.

作者信息

Geiger J M, Brindley C J

机构信息

Department of Clinical Research, F. Hoffmann-La Roche & Co. Ltd., Basel, Switzerland.

出版信息

Skin Pharmacol. 1988;1(4):230-6.

PMID:2978787
Abstract

The major plasma metabolite of acitretin (trans-acitretin) is its 13-cis isomer, cis-acitretin. Interconversion of cis-acitretin to trans-acitretin was demonstrated in man following administration of a single oral dose of cis-acitretin. Plasma concentrations of Ro 13-7652 (cis-acitretin) and Ro 10-1670 (trans-acitretin) were much higher after cis-acitretin administration than after trans-acitretin administration. Surprisingly, these high concentrations were not associated with a clear therapeutic effect in dermatoses (e.g. psoriasis) which are usually responsive to oral retinoids. Interactions between the cis and trans isomers formed in vivo may explain the difference in therapeutic activity of each stereoisomer when administered orally.

摘要

阿维A(反式阿维A)的主要血浆代谢产物是其13-顺式异构体,即顺式阿维A。单次口服顺式阿维A后,在人体内证实了顺式阿维A向反式阿维A的相互转化。给予顺式阿维A后,Ro 13-7652(顺式阿维A)和Ro 10-1670(反式阿维A)的血浆浓度比给予反式阿维A后高得多。令人惊讶的是,这些高浓度与通常对口服维甲酸有反应的皮肤病(如银屑病)的明确治疗效果无关。体内形成的顺式和反式异构体之间的相互作用可能解释了每种立体异构体口服给药时治疗活性的差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验